What are Agios Pharmaceuticals's profit margins?

Agios Pharmaceuticals (AGIO) runs a 90.0% gross margin and a -720.0% operating margin, with a -639.8% net margin.

Where do Agios Pharmaceuticals's ratios come from?

Every ratio is computed from Agios Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Agios Pharmaceuticals AGIO Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	90%+1.8pp	88.3%+1.0pp	87.2%-1.0pp	88.2%+0.7pp	87.5%-1.1pp
Operating margin	-720%+154pp	-873.9%+188pp	-1,061.8%+67.3pp	-1,129.1%+59.7pp	-1,188.9%-22.4pp
EBITDA margin	-712%+152pp	-864.3%+186pp	-1,050%+66.3pp	-1,116.3%+57.5pp	-1,173.8%-22.8pp
Free cash flow margin	-582.5%+116pp	-698.3%+226pp	-924.5%+76.2pp	-1,000.7%+89.6pp	-1,090.2%-17.5pp
Returns
Return on invested capital	-38.5%-3.1pp	-35.4%+0.2pp	-35.6%+11.0pp	-46.7%-5.4pp	-41.3%-4.5pp
Efficiency
Asset turnover	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Inventory turnover	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.2×0.0×
Liquidity
Current ratio	14.2×+2.7×	11.5×-2.4×	13.8×-0.7×	14.5×-4.0×	18.5×+6.6×
Quick ratio	13.6×+2.5×	11.1×-2.3×	13.4×-0.6×	14×-3.9×	17.9×+6.4×
Cash ratio	1.9×+0.8×	1.1×-0.2×	1.2×+0.1×	1.1×-0.4×	1.5×+0.6×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Interest coverage	-9.3×-0.9×	-8.4×-0.7×	-7.7×-0.2×	-7.5×+0.5×	-8×+0.9×
Per Share
Book value per share	$18.87-8.3%	$20.58-6.8%	$22.09-6.6%	$23.64-7.4%	$25.52-4.1%
Valuation
Market capitalization	$1.98B+24.9%	$1.59B-31.9%	$2.33B+20.5%	$1.94B+15.3%	$1.68B-10.4%
Enterprise value	$1.9B+23.8%	$1.54B-32.6%	$2.28B+20.0%	$1.9B+15.2%	$1.65B-10.9%
Price / sales	30×+0.6×	29.4×-22.7×	52.1×+4.7×	47.4×+2.0×	45.3×-6.0×
Price / book	1.8×+0.5×	1.3×-0.5×	1.8×+0.4×	1.4×+0.3×	1.1×-0.1×
EV / sales	28.8×+0.4×	28.5×-22.5×	51×+4.4×	46.6×+1.9×	44.6×-6.2×
Free cash flow yield	-19.4%+4.4pp	-23.8%-6.0pp	-17.8%+3.4pp	-21.1%+2.9pp	-24.1%-3.2pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Agios Pharmaceuticals's profit margins?: Agios Pharmaceuticals (AGIO) runs a 90.0% gross margin and a -720.0% operating margin, with a -639.8% net margin.
Where do Agios Pharmaceuticals's ratios come from?: Every ratio is computed from Agios Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.